Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Ampio Pharmaceuticals Inc | AMPE | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.62 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.62 | 0.62 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.62 - 8.298 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.62 | USD |
Ampio Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 266.25k | 832.02k | - | 0 | -8.63M | -10.37 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ampio Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/03/2024 | 13:33 | PR Newswire (US) | Ampio Pharmaceuticals Received Audit Opinion with Going.. |
| 3/25/2024 | 16:00 | PR Newswire (US) | Ampio Announces Voluntary Delisting and SEC Deregistration |
| 3/04/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 2/28/2024 | 14:49 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/28/2024 | 14:48 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in.. |
| 2/28/2024 | 14:47 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in.. |
| 2/28/2024 | 14:46 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
| 2/28/2024 | 14:45 | Edgar (US Regulatory) | Form RW - Registration Withdrawal Request |
| 2/15/2024 | 08:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/14/2024 | 16:45 | PR Newswire (US) | Ampio Provides Update on Results from Pre-IND Enabling.. |
| 1/25/2024 | 15:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/25/2024 | 15:18 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMPE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.99 | 1.05 | 0.62 | 0.8323938 | 49,314 | -0.37 | -37.37% |
| 3 Months | 1.89 | 2.47 | 0.62 | 1.58 | 72,472 | -1.27 | -67.20% |
| 6 Months | 2.73 | 7.47 | 0.62 | 4.12 | 303,587 | -2.11 | -77.29% |
| 1 Year | 4.18 | 8.298 | 0.62 | 4.49 | 343,132 | -3.56 | -85.17% |
| 3 Years | 540.00 | 601.50 | 0.62 | 142.18 | 1,769,391 | -539.38 | -99.89% |
| 5 Years | 171.00 | 894.00 | 0.62 | 245.45 | 2,049,483 | -170.38 | -99.64% |
Ampio Pharmaceuticals Description
| Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress. |
